Original article here Calla Lily joins $50M program targeting antibiotic resistance A new intravaginal drug delivery platform has been selected to investigate whether localized UTI treatment can reduce the collateral effects of systemic antibiotics. Written by Bree Foster, PhD Aug 11, 2026 New approaches aim to target infections while sparing the gut microbiome. credit: istock.com/Scharvik …